Cite
HARVARD Citation
Ferry, I. et al. (2018). Feasibility of Busulfan Melphalan and Stem Cell Rescue After 131I-MIBG and Topotecan Therapy for Refractory or Relapsed Metastatic Neuroblastoma. Journal of pediatric hematology/oncology. 40 (6), p. . [Online].